News

news item image

ARCS evolves into LifeSciences Australia as part of wider strategic change

11 June 2026

ARCS has announced it is now LifeSciences Australia, with the name change part of a strategic push to better support professionals across the expanding life sciences sector.

news item image

ARCS Australia launches Public Clinical Site Partnership, with Monash Health as founding member

26 May 2026

ARCS Australia Ltd has launched the ARCS Public Clinical Site Partnership, a new national model designed to strengthen the capability, visibility and sector connection of public clinical research sites across Australia. Monash Health has joined as a founding partner.

Read More
news item image

ARCS Australia welcomes National Health and Medical Research Strategy 2026–2036

22 May 2026

ARCS Australia has welcomed the release of the Australian Government’s National Health and Medical Research Strategy 2026–2036, describing it as an important step towards a more coordinated, capable and impact-focused health and medical research system.

Read More
news item image

ARCS urges Government to align clinical trials reform with workforce investment in 2026–27 Pre-Budget Submission

07 January 2026

ARCS Australia has submitted its 2026–27 Federal Pre-Budget Submission, calling on Government to ensure that investment in Australia’s clinical trials system is matched by targeted and sustained investment in workforce capability.

Read More
news item image

Strengthening Australia’s Clinical Trials Workforce – White paper

19 November 2025

ARCS Australia has released a new white paper, Strengthening Australia’s Clinical Trials Workforce: ARCS Clinical Research Workforce Capacity Summit Insights and Strategic Blueprint. The report brings together insights from across government, health services, universities, industry and the clinical workforce to outline practical steps for building a sustainable, skilled and nationally coordinated clinical trials workforce in Australia. This work is designed to support Australia’s ambition to remain a leading destination for clinical trials, improve access to innovative therapies for patients, and ensure the workforce is recognised, supported and prepared for future growth

Read More
news item image

ARCS Australia Welcomes Two New Board Members

19 September 2025

ARCS Australia is pleased to announce the appointment of two highly respected leaders in the Australian Lifesciences sector, Anne O’Neill PSM MMPP and Associate Professor Tam Nguyen FMPP, following the recent board election.

Read More
news item image

National Clinical Research Workforce Capability and Capacity Summit

22 July 2025

ARCS Australia and Macquarie University have announced a new partnership to deliver the inaugural Clinical Research Workforce Capability and Capacity Summit, to be held at Macquarie University on 2 September 2025. This national Summit will address the urgent and growing need to build a sustainable, future-ready workforce for clinical research in Australia—an essential foundation for the country’s ability to conduct world-class research, attract global trials, and ensure timely access to innovative therapies.

Read More
news item image

2025 MTP Awards Sector 2025 Winners

03 July 2025

The MedTech and Pharmaceutical (MTP) Sector Awards celebrates individuals each year who have made significant contributions to the sector. Nominees can come from any occupation within the sector including Regulatory Affairs, Clinical Research, Pharmacovigilance, Medical Affairs/Operations/Information, GMP, Quality, Health Economics etc, and nominees must be an ARCS Australia Professional member. Members are recognised for their contributions to the profession's advancement, dedicated service, mentorship, strong leadership, or as rising leaders.

Read More
news item image

ARCS Australia Welcomes Release of NSW Innovation Blueprint 2035

31 March 2025

ARCS Australia Ltd, the peak body representing life sciences professionals in the medtech and pharmaceutical sectors, strongly supports the release of the NSW Innovation Blueprint 2035. The Blueprint outlines a long-term, strategic vision for NSW as a global leader in innovation and recognises the critical role of the life sciences sector in delivering health, economic and social benefits. With a focus on advanced manufacturing, clinical trials, vaccine technologies, and commercialisation, the Blueprint aligns closely with ARCS Australia's mission to build workforce capability and support the growth of innovative businesses across the therapeutic goods sector.

Read More
news item image

ARCS Statement on the 2025–26 Federal Budget

27 March 2025

ARCS Australia welcomes the 2025–26 Federal Budget and acknowledges its implications for our members working to advance innovation in healthcare across the medtech and pharmaceutical sectors.

Read More

ARCS Launches Clinical Trial Service Provision Position Paper at 2024 ARCS Conference following 2023 Sydney Summit

18 June 2024

On 22 November 2023, ARCS orchestrated a pivotal summit focusing on the ICH-GCP E6(R3) renovation, emphasising the power of collaboration for successful implementation.

Read More

Media Release: ARCS Unveils Transformative Initiatives to Elevate Professional Standards in the Medtech and Pharmaceutical Sector

13 June 2024

ARCS is proud to launch a comprehensive Core Competency Framework tailored for the Medtech and Pharmaceutical sectors.

Read More

Press Release: ARCS Australia Welcomes the Establishment of the National One Stop Shop for Clinical Trials

02 May 2024

ARCS Australia is delighted to endorse the Australian Government's new initiative, the National One Stop Shop for clinical trials, announced today by the Minister for Health and Aged Care, the Hon Mark Butler MP.

Read More

ARCS Hosts Successful Webinar on Reform and Reimbursement: Health Technology Assessment Review with Elizabeth De Somer, Medicines Australia

24 April 2024

On April 23, 2024, the ARCS Australia conducted a highly anticipated free Health Economics Interest Area Webinar. Featuring Medicines Australia CEO, Elizabeth De Somer.

Read More

Media Release: Talking HealthTech Announced as Official Media Partner for the 2024 ARCS Annual Conference

03 April 2024

Talking HealthTech is proud to be an official media partner for the 2024 ARCS Annual Conference.

Read More

Media Release: ARCS Australia Announces BioBeacon: A Landmark Event to Spotlight Life Sciences Startups

26 March 2024

ARCS Australia Ltd, the peak organisation dedicated to the advancement of professionals in the MedTech, Biotech and Pharmaceutical sector, is thrilled to announce the inaugural BioBeacon event, set to take place on 14 June 2024 at ICC Sydney.

Read More

ARCS Australia and Chrysalis Advisory Partnership

16 October 2023

We are excited to announce our partnership with Chrysalis Advisory.

Read More
news item image

REDI initiative awards contracts to ARCS Australia and SeerPharma for workforce skills gap training and education

18 March 2021

MTPConnect today announced its selection of industry training providers to deliver new programs addressing key skills gaps in the medical technology, biotechnology and pharmaceutical (MTP) sector workforce.

Read More
news item image

National coordination of clinical trials needed to build post COVID-19 sector

04 August 2020

A leading group of Contract Research Organisations (CROs) under the leadership of ARCS Australia are calling on the federal government to improve policies and processes around national coordination of clinical trials in Australia.

Read More
news item image

ARCS to put patients at the centre of healthcare

05 August 2019

Close to 1200 professionals from the healthcare sector will gather in Sydney tomorrow to attend the three-day ARCS 2019 annual conference on Putting patients at the centre of healthcare.

Read More
news item image

Joint industry pre-election statement on health research and development

09 May 2019

Industry is a key driver of better health outcomes in our health system, and industry-driven research and development (R&D) activities are critical to achieve this.

Read More